Melanoma treatment mystery gets new answers from mathematical model
New research from the University of Texas at Arlington helps explain a longstanding puzzle in melanoma treatment: why continuous targeted therapy performed better than planned on-and-off treatment schedules in clinical trials, despite promising laboratory studies of intermittent dosing. If you liked the article, do not forget to share it with your friends. Follow us on Google…